The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen (Q22252194)

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Effect of C-reactive protein on chemokine expression in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Influence of aspirin on inflammatory markers in patients after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Generation of C-reactive protein and complement components in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Obesity, metabolic syndrome X, and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Statins for Atherosclerosis — As Good as It Gets?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

The acute phase protein response in patients receiving subcutaneous IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Associations between cardiorespiratory fitness and C-reactive protein in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein and the future risk of thromboembolic stroke in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Blood pressure, C-reactive protein, and risk of future cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Current concepts of the pathogenesis of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Impact of infectious burden on progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Serum amyloid A protein in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Function of C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

C-reactive protein: a new cardiovascular risk factor?

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJCARD.2005.01.068

7 January 2021